We are live on ! Find out more
PHAT icon

Phathom Pharmaceuticals
PHAT

40 hedge funds and large institutions have $677M invested in Phathom Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

88.91% more ownership

Funds ownership: 0% → 88.91% (+89%)

Holders
40
Holders Change
+40
Holders Change %
–
% of All Funds
0.79%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.1%
New
40
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FM
Frazier Management
Washington
+$183M
2
RCM
RA Capital Management
Massachusetts
+$91.7M
3
Invesco
Invesco
Georgia
+$52.8M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$36.9M
5
A
Abingworth
United Kingdom
+$30.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$234K +$189K +7,528 New
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
$218K +$176K +6,986 New
AIG
28
American International Group
New York
$210K +$169K +6,738 New
Goldman Sachs
29
Goldman Sachs
New York
$202K +$163K +6,492 New
Deutsche Bank
30
Deutsche Bank
Germany
$121K +$98.7K +3,926 New
JP Morgan Chase
31
JP Morgan Chase
New York
$109K +$88.2K +3,509 New
SO
32
STRS Ohio
Ohio
$87K +$70.4K +2,800 New
Citigroup
33
Citigroup
New York
$67K +$54.2K +2,158 New
Legal & General Group
34
Legal & General Group
United Kingdom
$66K +$53.2K +2,117 New
Bank of America
35
Bank of America
North Carolina
$58K +$46.6K +1,855 New
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$42K +$34K +1,352 New
AIP
37
Ameritas Investment Partners
Nebraska
$29K +$23.2K +925 New
Wells Fargo
38
Wells Fargo
California
$27K +$22K +876 New
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$22K +$17.4K +693 New
PNC Financial Services Group
40
PNC Financial Services Group
Pennsylvania
$3K +$2.14K +85 New
1
2

PHAT Hedge Fund Activity: Q4 2019 in Review

40 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Phathom Pharmaceuticals (PHAT) for Q4 2019, worth a combined $677M.

Buyers outnumbered sellers: 40 funds opened new PHAT positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Frazier Management, opening a new position worth an estimated $183M.

  • 40 institutional investors held Phathom Pharmaceuticals (PHAT) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $677M of Phathom Pharmaceuticals stock for Q4 2019.
  • 40 funds opened new Phathom Pharmaceuticals positions in Q4 2019 and 0 closed out, a net change of +40 holders.
  • The largest Phathom Pharmaceuticals buyer in Q4 2019 was Frazier Management, an estimated $183M added.

Based on aggregated 13F filings for Q4 2019.